Allspring Global Investments
PRME icon

Allspring Global Investments’s Prime Medicine PRME Stock Holding History

Allspring Global Investments’s Portfolio PRME Stock Details PRME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-3,067
Closed -$29.3K – 2630
2023
Q3 		$29.3K Sell
3,067
-8,374
-73% -$109K ﹤0.01% 2422
2023
Q2 		$168K Buy
11,441
+10,290
+894% +$144K ﹤0.01% 1865
2023
Q1 		$14.2K Buy
+1,151
New +$18.7K ﹤0.01% 2552

Other funds holding PRME

AI
Alphabet Inc Mountain View, California $4.02B AUM 215.74% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Allspring Global Investments's PRME Position: Q4 2023 in Review

Allspring Global Investments sold out of Prime Medicine (PRME) in Q4 2023, closing a stake of 3,067 shares — an estimated $29.3K sold.

Allspring Global Investments first reported a position in PRME in Q1 2023 and held it in 3 quarters. The position peaked at $168K in Q2 2023. 105 funds tracked by Wall St. Rank hold PRME as of Q4 2023.

  • Allspring Global Investments reported no remaining Prime Medicine position as of Q4 2023 after selling out during the quarter.
  • Allspring Global Investments sold 3,067 Prime Medicine shares in Q4 2023, an estimated $29.3K.
  • Allspring Global Investments first reported a position in Prime Medicine in Q1 2023 and held it in 3 quarters.
  • Allspring Global Investments's Prime Medicine position peaked at $168K in Q2 2023.
  • 105 funds tracked by Wall St. Rank held Prime Medicine as of Q4 2023.

Based on Allspring Global Investments's 13F filing for Q4 2023, filed 25 Jan 2024.